Harris K M, Remler D K
Institute for Health Services Research, Tulane University Medical Center, LA 70112-2699, USA.
Health Serv Res. 1998 Dec;33(5 Pt 1):1337-60.
To clarify the issues of generalizability arising from the use of instrumental variable (IV) methods to estimate treatment effects in nonexperimental medical outcome studies.
We generate Monte Carlo data designed to resemble typical data sets where detailed health status information is unavailable and the treatment assignment process is unobserved. The model used to generate our data makes the realistic assumption that unobservable health status characteristics of patients influence the treatment assignment process and the effectiveness of treatment.
We use Monte Carlo data to illustrate the circumstances where IV estimates generalize to an unobservable patient subpopulation and those where IV estimates generalize to the entire patient population represented by the sample used in the analysis. We also simulate the effect of two policy changes that affect practice patterns. Further, we show that IV estimates are useful for predicting the effect of these changes on treatment effectiveness when the subpopulation to which the IV estimate refers is the same or very similar to the population whose treatment status is affected by the policy change.
Health services researchers cannot take for granted that IV estimates generalize to the same population represented by the sample used for analysis. Instead, researchers must rely on their knowledge of clinical practice and theory regarding the treatment assignment process in interpreting their results and in predicting the effect of changes in practice patterns.
阐明在非实验性医学结局研究中使用工具变量(IV)方法估计治疗效果时出现的可推广性问题。
我们生成了蒙特卡洛数据,旨在模拟典型数据集,在这些数据集中,详细的健康状况信息不可用,且治疗分配过程未被观察到。用于生成我们数据的模型做出了一个现实的假设,即患者不可观察的健康状况特征会影响治疗分配过程和治疗效果。
我们使用蒙特卡洛数据来说明IV估计可推广到不可观察的患者亚群的情况,以及IV估计可推广到分析中所使用样本所代表的整个患者群体的情况。我们还模拟了两种影响实践模式的政策变化的效果。此外,我们表明,当IV估计所涉及的亚群与治疗状态受政策变化影响的人群相同或非常相似时,IV估计对于预测这些变化对治疗效果的影响是有用的。
卫生服务研究人员不能想当然地认为IV估计可推广到用于分析的样本所代表的同一人群。相反,研究人员在解释其结果和预测实践模式变化的影响时,必须依靠他们对临床实践和治疗分配过程理论的了解。